-
Signature
-
/s/ James J. Comitale as Attorney-In-Fact
-
Issuer symbol
-
OLLI
-
Transactions as of
-
27 Nov 2024
-
Net transactions value
-
-$273,600
-
Form type
-
4
-
Filing time
-
02 Dec 2024, 17:37:20 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
OLLI |
Common Stock, par value $0.001 per share |
Options Exercise |
$141,360 |
+2,400 |
+5% |
$58.90 |
50,600 |
27 Nov 2024 |
Direct |
F1 |
| transaction |
OLLI |
Common Stock, par value $0.001 per share |
Sale |
$246,240 |
-2,400 |
-4.7% |
$102.60 |
48,200 |
27 Nov 2024 |
Direct |
F1, F2 |
| transaction |
OLLI |
Common Stock, par value $0.001 per share |
Options Exercise |
$77,520 |
+2,400 |
+5% |
$32.30 |
50,600 |
27 Nov 2024 |
Direct |
F1 |
| transaction |
OLLI |
Common Stock, par value $0.001 per share |
Sale |
$246,240 |
-2,400 |
-4.7% |
$102.60 |
48,200 |
27 Nov 2024 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
OLLI |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-2,400 |
-9.1% |
$0.000000 |
23,852 |
27 Nov 2024 |
Common StockStock |
2,400 |
$58.90 |
Direct |
F1, F4 |
| transaction |
OLLI |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-2,400 |
-6.8% |
$0.000000 |
32,866 |
27 Nov 2024 |
Common Stock |
2,400 |
$32.30 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: